<DOC>
	<DOCNO>NCT01483586</DOCNO>
	<brief_summary>This research do evaluate safety efficacy investigational Kanglaite gelcap ( KLTc ) PSA men prostate cancer give twelve month .</brief_summary>
	<brief_title>Safety Efficacy Kanglaite Gelcaps Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>confirm adenocarcinoma prostate undergone definitive treatment ( surgery , surgery radiation therapy , cryotherapy , radiation therapy brachytherapy ) primary prostate tumor rise PSA life expectancy great 6 month Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 use dietary/herbal supplement ( e.g . saw palmetto , selenium , etc . ) stable least 2 month prior screen patient agrees stop change dose participate study . Adequate hepatic function serum bilirubin ≤ 1.5 time upper institutional limit normal , ALT AST ≤ 2.5 time upper institutional limit normal Adequate renal function serum creatinine ≤ 1.5 time upper institutional limit normal Adequate hematologic function ( absolute neutrophil count ≥ 1,500 mm3 platelet ≥ 100,000 mm3 ) All electrolyte ( include potassium , sodium , serum ionized calcium ) must within normal limit Patients evidence metastatic disease would exclude , except presence positive lymph node surgical pathology . Similarly , patient radiological evidence lymph node &lt; 2 cm lack pathological confirmation would eligible Patients PSA double time &lt; 6months screen would exclude Patients meet Phoenix criterion biochemical failure ( nadir + ≥2ng/mL increase serum PSA ) wish additional conventional therapy Any concurrent malignancy adequately treat basal squamous cell skin cancer superficial bladder cancer Any psychiatric disorder dementia would prohibit patient understand render informed consent fully comply protocol treatment followup Inability swallow capsule Patients know history gastrointestinal disease , surgery malabsorption could potentially impact absorption study drug Patients require use feed tube Receipt prior chemotherapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>